Gimme Care vs GoodRx
Gimme Care costs $19 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Gimme Care
Best for: semaglutide at $130/month, 39% below the typical price
Visit Gimme Care →
If you are choosing between Gimme Care and GoodRx, the first difference is cost: Gimme Care is $19 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. Gimme Care leads our six-part score, 8.7 to 6.9.
Gimme Care vs GoodRx price
Gimme Care is the cheaper way in: $130 a month against $149 a month at GoodRx. That is $19 less each month (13% lower), or about $228 over a year of treatment.
Drug by drug: Tirzepatide is cheaper at Gimme Care ($163 a month vs $299 a month).
Medications and formats
Both sell tirzepatide; only Gimme Care lists semaglutide; only GoodRx lists orforglipron.
On format, Gimme Care prices compounded injections, while GoodRx prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
Gimme Care lists 51 states, and GoodRx lists 50 states.
They overlap in 50 states. Gimme Care alone covers District of Columbia.
Pricing
Gimme Care
GoodRx
What each price covers
Gimme Care's price also covers the clinician visit, the medication itself and shipping, which GoodRx does not claim.
Gimme Care is silent on lab work and coaching.
GoodRx does not say what its price includes.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
Gimme Care
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
GoodRx
Inclusions not disclosed.
Where each one scores higher
Overall, Gimme Care scores 8.7 and GoodRx 6.9 out of 10.
Gimme Care is stronger on value (8.1 vs 5.0), user experience (8.0 vs 5.0), trust & safety (8.5 vs 6.0) and support (7.0 vs 5.0).
Effectiveness and accessibility are within half a point.
Gimme Care
8.7/10
GoodRx
6.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Gimme Care nor GoodRx has an FDA warning letter on record with us.
Features & Coverage
| Feature | Gimme Care | GoodRx |
|---|---|---|
| Starting Price | ✓$130/mo | $149/mo |
| Features | 5 features | ✓6 features |
| States Available | ✓51 | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Gimme Care
Gimme Care sells compounded semaglutide at $130-$160/mo and compounded tirzepatide at $163-$199/mo, microdose options included. It is LegitScript verified, available in all 50 states plus DC, with no membership fees.
Read our full Gimme Care review →About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →Pros & Cons
Gimme Care
What we like
- Semaglutide costs $130 a month, 29% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $163 a month, 35% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Gimme Care
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Gimme Care wins this one, 8.7 to 6.9, above all for semaglutide at $130/month, 39% below the typical price. It also costs $19 less each month than GoodRx. GoodRx fits better if oral orforglipron alongside the injectables is your priority.
Choose Gimme Care if…
You want semaglutide at $130/month, 39% below the typical price and an opening price near $130 a month.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →Gimme Care vs GoodRx: FAQ
Close alternatives to Gimme Care and GoodRx
- Gimme Care vs Bioverse
- Gimme Care vs Alternate Health Club
- Gimme Care vs DoctorAdam
- Gimme Care vs Longevixx
- GoodRx vs Found
- GoodRx vs Kin Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.